Nucleosides and Nucleotides · 1994 · 27 citations · 16 references
PharmacyMedicinal ChemistryMolecular BiologyMolecular VirologyStructural BiologyStructure-activity RelationshipsAntiretroviral TherapyAntiviral PharmacologyLigand BindingNucleic Acid Drug DesignOligonucleotide ChemistryRna ModificationAntiviral Structure-activity RelationshipsAssayChemical Modification Of OligonucleotidesChemical Structure-activity RelationshipsNucleoside AnalogsNucleoside Reverse Transcriptase InhibitorsOligonucleotide Backbone Modifications
Abstract 5′-End-modified pentadecadeoxyribonucleotides (15mers) with a sequence complementary to the tat 2nd splicing acceptor region of human immunodeficiency virus type 1 (HIV-1) were prepared and evaluated for anti-HIV-1 activity. The structures of modified 15mers were confirmed by negative ion LSI mass spectroscopy, and the anti-HIV-1 activities were evaluated in vitro by MTT assay using MT-4 cells. While the unmodified 15mer had no activity in our assay system, the 15mers bearing modifications with trityl-type substituents at the 5′-end showed potent anti-HIV-1 activities.
16
Heinz Schaller, G. Weimann, B. Lerch et al. · Journal of the American Chemical Society · 1963 · 402 citations
Robert L. Letsinger, G R Zhang, Di Sun et al. · Proceedings of the National Academy of Sciences · 1989 · 303 citations · Full text
Marjorie Smith, D. H. Rammler, I. Goldberg et al. · Journal of the American Chemical Society · 1962 · 283 citations
Glenn D. Hoke, Kenneth Draper, Susan M. Freier et al. · Nucleic Acids Research · 1991 · 248 citations · Full text